Liver Transplantation for the Nonhepatologist

References

1. • Oustecky D.H.
   • Riera A.R.
   • Rothstein K.D.
   Long-term management of the liver transplant recipient: pearls for the practicing gastroenterologist.
   Gastroenterol Clin North Am. 2011; 40: 659-681
   View in Article

   • Google Scholar
2. • Desai R.
   • Jamieson N.V.
   • Gimson A.E.
   • et al.
   Quality of life up to 30 years following liver transplantation.
   Liver Transpl. 2008; 14: 1473-1479
   View in Article

   • Google Scholar
3. • Martin P.
   • DiMartini A.
   • Feng S.
   • et al.
   Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.
   Hepatol. 2014; 59: 1144-1165
   View in Article

   • Google Scholar
4. • Mansour D.
   • McPherson S.
   Management of decompensated cirrhosis.
   Clin Med (Lond). 2018; 18: s60-s65
   View in Article

   • Google Scholar
5. • Seaberg E.C.
   • Belle S.H.
   • Beringer K.C.
   • et al.
   Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS Liver Transplant Registry.
   Clin Transpl. 1998; : 17-37
   View in Article

   • Google Scholar
6. • Ganschow R.
   • Pollok J.M.
   • Jankofsky M.
   • et al.
   The role of everolimus in liver transplantation.
   Clin Exp Gastroenterol. 2014; 7: 329-343
   View in Article

   • Google Scholar
7. • Rubin A.
   • Aguilera V.
   • Berenguer M.
   Liver transplantation and hepatitis C.
   Clin Res Hepatol Gastroenterol. 2011; 35: 805-812
   View in Article

   • Google Scholar
8. • Dababneh Y.
   • Mousa O.Y.
   Liver transplantation.
   StatPearls Publishing, Treasure Island (FL)2022
   View in Article

   • Google Scholar
9. • Kwong A.J.
   • Ebel N.H.
   • Kim W.R.
   • et al.
   OPTN/SRTR 2020 annual data report: liver.
   Am J Transplant. 2022; 22: 204-309
   View in Article

   • Google Scholar
10. • Nguyen T.A.
    • DeShazo J.P.
    • Thacker L.R.
    • et al.
    The worsening profile of alcoholic hepatitis in the United States.
    Alcohol Clin Exp Res. 2016; 40: 1295-1303
    View in Article

    • Google Scholar
11. • Arguedas M.R.
    • Abrams G.A.
    • Krowka M.J.
    • et al.
    Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation.
    Hepatol. 2003; 37: 192-197
    View in Article

    • Google Scholar
12. • Gupta S.
    • Castel H.
    • Rao R.V.
    • et al.
    Improved survival after liver transplantation in patients with hepatopulmonary syndrome.
    Am J Transplant. 2010; 10: 354-363
    View in Article

    • Google Scholar
13. • Kulkarni S.
    • Malago M.
    • Cronin 2nd, D.C.
    Living donor liver transplantation for pediatric and adult recipients.
    Nat Clin Pract Gastroenterol Hepatol. 2006; 3: 149-157
    View in Article

    • Google Scholar
14. • Thuluvath P.J.
    • Yoo H.Y.
    Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Liver Transpl. 2004; 10: 1263-1268
    View in Article

    • Google Scholar
15. • Liang W.
    • Wu L.
    • Ling X.
    • et al.
    Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Liver Transpl. 2012; 18: 1226-1236
    View in Article

    • Google Scholar
16. • Hoehn R.S.
    • Wilson G.C.
    • Wima K.
    • et al.
    Comparing living donor and deceased donor liver transplantation: a matched national analysis from 2007 to 2012.
    Liver Transpl. 2014; 20: 1347-1355
    View in Article

    • Google Scholar
17. • Broering D.C.
    • Sterneck M.
    • Rogiers X.
    Living donor liver transplantation.
    J Hepatol. 2003; 38: S119-S135
    View in Article

    • Google Scholar
18. • Durand F.
    • Valla D.
    Assessment of prognosis of cirrhosis.
    Semin Liver Dis. 2008; 28: 110-122
    View in Article

    • Google Scholar
19. • Tsoris A.
    • Marlar C.A.
    Use of the child Pugh score in liver disease.
    StatPearls Publishing, Treasure Island (FL)2022
    View in Article

    • Google Scholar
20. • Fernandez-Esparrach G.
    • Sanchez-Fueyo A.
    • Gines P.
    • et al.
    A prognostic model for predicting survival in cirrhosis with ascites.
    J Hepatol. 2001; 34: 46-52
    View in Article

    • Google Scholar
21. • Burra P.
    • Samuel D.
    • Sundaram V.
    • et al.
    Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation.
    J Hepatol. 2021; 75: S178-S190
    View in Article

    • Google Scholar
22. • Godfrey E.L.
    • Malik T.H.
    • Lai J.C.
    • et al.
    The decreasing predictive power of MELD in an era of changing etiology of liver disease.
    Am J Transplant. 2019; 19: 3299-3307
    View in Article

    • Google Scholar
23. • Biggins S.W.
    • Rodriguez H.J.
    • Bacchetti P.
    • et al.
    Serum sodium predicts mortality in patients listed for liver transplantation.
    Hepatol. 2005; 41: 32-39
    View in Article

    • Google Scholar
24. • Ruf A.E.
    • Kremers W.K.
    • Chavez L.L.
    • et al.
    Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.
    Liver Transpl. 2005; 11: 336-343
    View in Article

    • Google Scholar
25. • Kim W.R.
    • Biggins S.W.
    • Kremers W.K.
    • et al.
    Hyponatremia and mortality among patients on the liver-transplant waiting list.
    N Engl J Med. 2008; 359: 1018-1026
    View in Article

    • Google Scholar
26. • Nagai S.
    • Chau L.C.
    • Schilke R.E.
    • et al.
    Effects of allocating livers for transplantation based on model for end-stage liver disease-sodium scores on patient outcomes.
    Gastroenterol. 2018; 155: 1451-1462.e3
    View in Article

    • Google Scholar
27. • Allen A.M.
    • Heimbach J.K.
    • Larson J.J.
    • et al.
    Reduced access to liver transplantation in women: role of height, MELD exception scores, and renal function underestimation.
    Transplantation. 2018; 102: 1710-1716
    View in Article

    • Google Scholar
28. • Kim W.R.
    • Mannalithara A.
    • Heimbach J.K.
    • et al.
    MELD 3.0: the model for end-stage liver disease updated for the modern era.
    Gastroenterology. 2021; 161: 1887-1895.e4
    View in Article

    • Google Scholar
29. • Parikh N.D.
    • Singal A.G.
    Model for end-stage liver disease exception points for treatment-responsive hepatocellular carcinoma.
    Clin Liver Dis (Hoboken). 2016; 7: 97-100
    View in Article

    • Google Scholar
30. • Freeman Jr., R.B.
    • Gish R.G.
    • Harper A.
    • et al.
    Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.
    Liver Transpl. 2006; 12: S128-S136
    View in Article

    • Google Scholar
31. • Mazzaferro V.
    • Regalia E.
    • Doci R.
    • et al.
    Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.
    N Engl J Med. 1996; 334: 693-699
    View in Article

    • Google Scholar
32. • Giard J.M.
    • Dodge J.L.
    • Terrault N.A.
    Superior wait-list outcomes in patients with alcohol-associated liver disease compared with other indications for liver transplantation.
    Liver Transpl. 2019; 25: 1310-1320
    View in Article

    • Google Scholar
33. • Nagai S.
    • Safwan M.
    • Kitajima T.
    • et al.
    Disease-specific waitlist outcomes in liver transplantation - a retrospective study.
    Transpl Int. 2021; 34: 499-513
    View in Article

    • Google Scholar
34. • Choudhary N.S.
    • Saigal S.
    • Bansal R.K.
    • et al.
    Acute and chronic rejection after liver transplantation: what a clinician needs to know.
    J Clin Exp Hepatol. 2017; 7: 358-366
    View in Article

    • Google Scholar
35. • Lucey M.R.
    • Terrault N.
    • Ojo L.
    • et al.
    Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.
    Liver Transpl. 2013; 19: 3-26
    View in Article

    • Google Scholar
36. • Ayoub W.S.
    • Esquivel C.O.
    • Martin P.
    Biliary complications following liver transplantation.
    Dig Dis Sci. 2010; 55: 1540-1546
    View in Article

    • Google Scholar
37. • Issa D.H.
    • Alkhouri N.
    Long-term management of liver transplant recipients: a review for the internist.
    Cleve Clin J Med. 2015; 82: 361-372
    View in Article

    • Google Scholar
38. • McAlister V.C.
    • Haddad E.
    • Renouf E.
    • et al.
    Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis.
    Am J Transplant. 2006; 6: 1578-1585
    View in Article

    • Google Scholar
39. • Montalbano M.
    • Neff G.W.
    • Yamashiki N.
    • et al.
    A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications.
    Transplant. 2004; 78: 264-268
    View in Article

    • Google Scholar
40. • Jin Y.P.
    • Valenzuela N.M.
    • Ziegler M.E.
    • et al.
    Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus.
    Am J Transplant. 2014; 14: 806-819
    View in Article

    • Google Scholar
41. • De Simone P.
    • Nevens F.
    • De Carlis L.
    • et al.
    Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.
    Am J Transplant. 2012; 12: 3008-3020
    View in Article

    • Google Scholar
42. • Rodriguez-Peralvarez M.
    • Perez-Medrano I.
    • Guerrero-Misas M.
    • et al.
    Everolimus is safe within the first month after liver transplantation.
    Transpl Immunol. 2015; 33: 146-151
    View in Article

    • Google Scholar
43. • Guan T.W.
    • Lin Y.J.
    • Ou M.Y.
    • et al.
    Efficacy and safety of everolimus treatment on liver transplant recipients: a meta-analysis.
    Eur J Clin Invest. 2019; 49: e13179
    View in Article

    • Google Scholar
44. • Di Maira T.
    • Little E.C.
    • Berenguer M.
    Immunosuppression in liver transplant.
    Best Pract Res Clin Gastroenterol. 2020; 46-47: 101681
    View in Article

    • Google Scholar
45. • Colmenero J.
    • Tabrizian P.
    • Bhangui P.
    • et al.
    De novo malignancy after liver transplantation: risk assessment, prevention, and management-guidelines from the ILTS-SETH consensus conference.
    Transplant. 2022; 106: e30-e45
    View in Article

    • Google Scholar
46. • Pagadala M.
    • Dasarathy S.
    • Eghtesad B.
    • et al.
    Posttransplant metabolic syndrome: an epidemic waiting to happen.
    Liver Transpl. 2009; 15: 1662-1670
    View in Article

    • Google Scholar
47. • Levy C.
    • Harnois D.M.
    • Angulo P.
    • et al.
    Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study.
    Liver Int. 2005; 25: 117-121
    View in Article

    • Google Scholar
48. • Brunova J.
    • Kratochvilova S.
    • Stepankova J.
    Osteoporosis therapy with denosumab in organ transplant recipients.
    Front Endocrinol (Lausanne). 2018; 9: 162
    View in Article

    • Google Scholar
49. • Camacho P.M.
    • Petak S.M.
    • Binkley N.
    • et al.
    American association of clinical endocrinologists/american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update.
    Endocr Pract. 2020; 26: 1-46
    View in Article

    • Google Scholar
50. • Rodriguez-Aguilar E.F.
    • Perez-Escobar J.
    • Sanchez Herrera D.
    • et al.
    Bone disease and liver transplantation: a review.
    Transplant Proc. 2021; 53: 2346-2353
    View in Article

    • Google Scholar
51. • Herrero J.I.
    • Espana A.
    • Quiroga J.
    • et al.
    Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
    Liver Transpl. 2005; 11: 1100-1106
    View in Article

    • Google Scholar
52. • McGuire B.M.
    • Rosenthal P.
    • Brown C.C.
    • et al.
    Long-term management of the liver transplant patient: recommendations for the primary care doctor.
    Am J Transplant. 2009; 9: 1988-2003
    View in Article

    • Google Scholar
53. • Valour F.
    • Conrad A.
    • Ader F.
    • et al.
    Vaccination in adult liver transplantation candidates and recipients.
    Clin Res Hepatol Gastroenterol. 2020; 44: 126-134
    View in Article

    • Google Scholar
54. • Stucchi R.S.B.
    • Lopes M.H.
    • Kumar D.
    • et al.
    Vaccine recommendations for solid-organ transplant recipients and donors.
    Transplant. 2018; 102: S72-S80
    View in Article

    • Google Scholar
55. • John B.V.
    • Deng Y.
    • Khakoo N.S.
    • et al.
    Coronavirus disease 2019 vaccination is associated with reduced severe acute respiratory syndrome coronavirus 2 infection and death in liver transplant recipients.
    Gastroenterol. 2022; 162: 645-647.e2
    View in Article

    • Google Scholar
56. • Moon A.M.
    • Webb G.J.
    • Garcia-Juarez I.
    • et al.
    SARS-CoV-2 infections among patients with liver disease and liver transplantation who received COVID-19 vaccination.
    Hepatol Commun. 2022; 6: 889-897
    View in Article

    • Google Scholar
57. • Ekpanyapong S.
    • Reddy K.R.
    Liver and biliary tract disease in patients with COVID-19 infection.
    Gastroenterol Clin North Am. 2022;
    View in Article

    • Google Scholar